Senator’s Wife Secretly Gave Him Psilocybin to Alleviate Depression
Senator Larry Campbell, who struggles with depression, PTSD, and “getting old,” reveals that psilocybin microdoses helped improve his mood.
James Hallifax is an entrepreneur who co-founded The Psychedelic Investor, a media company focused on investing in psychedelic medicines which treat mental health conditions. Together with his business partner, they have grown their YouTube Channel to be the largest Channel dedicated to Investing in Psychedelics. Through their partnership with Psychedelic Spotlight, James aims to help educate retail investors on the potential for substances like LSD, MDMA and Magic Mushrooms to heal, and for early investors who make the right choices to make a lot of money. Rather than focus on day to day stock movements, James follows the underlying science of the industry, to help people understand which companies are the most likely to succeed long term.
Senator Larry Campbell, who struggles with depression, PTSD, and “getting old,” reveals that psilocybin microdoses helped improve his mood.
From May 21-26, for the first time, the Davos Forum will feature The House of Psychedelics. Here’s why that matters for the psychedelics industry.
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks.
The history of MDMA is fascinating, and it is still being written.
Researchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.
Psychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.
Wesana Health reaches a major strategic pivot point. Our resident Psychedelic Investor examines what this means for the company and industry at large.
Science just keeps discovering how cool and beneficial mushrooms are, with or without psilocybin.
This is one of the billionaire’s most explicit acknowledgments of the power of psychedelics for mental health applications.
Field Trip Health plans to split into two independent, publicly traded companies: Field Trip Health and Wellness and Reunion Neuroscience.
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.